Instituto: INSTITUTO DE BIOLOGIA MOLECULAR Y CELULAR DEL CANCER DE SALAMANCA

CABERGOLINE OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF FOR USE IN PREVENTION OR DELAY OF POSTPREGNANCY BREAST CANCER IN A FEMALE MAMMAL

JESUS PEREZ LOSADA